Amphastar Pharmaceuticals (AMPH) Non-Current Deferred Revenue (2013 - 2017)
Amphastar Pharmaceuticals (AMPH) recorded Non-Current Deffered Revenue of $1.22 million in Q3 2017, up 623.2% from $168,000 a year earlier and up 187.2% from the prior quarter.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Non-Current Deferred Revenue (2013 - 2017) Analysis & Trends
At the end of FY2016, Amphastar Pharmaceuticals reported Non-Current Deffered Revenue of $97,000, down 92.8% from FY2015.
- Annual Non-Current Deffered Revenue has declined for three straight years, with a three-year compound annual growth rate of -66.7% (FY2013 to FY2016).
- Across earlier years, Non-Current Deffered Revenue came in at $1.34 million in FY2015 (-32.4%), $1.98 million in FY2014 (-24.5%) and $2.63 million in FY2013.
- The Q3 2017 figure is the highest quarterly Non-Current Deffered Revenue since Q4 2015.
- On a year-over-year basis, Non-Current Deffered Revenue rose in two of the last eight quarters, with growth averaging 45.3%.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 623.2% in Q3 2017, against a decline of 92.8% in Q4 2016 at the low end.
- Per Business Quant, the preceding three quarters came in at $423,000 (Q2 2017), $280,000 (Q1 2017) and $97,000 (Q4 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Amphastar Pharmaceuticals | 1.25 Bn | 156.30 Mn | 99.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 1.22 Mn |
| Jun 30, 2017 | 423,000.00 |
| Mar 31, 2017 | 280,000.00 |
| Dec 31, 2016 | 97,000.00 |
| Sep 30, 2016 | 168,000.00 |
| Jun 30, 2016 | 166,000.00 |
| Mar 31, 2016 | 1.18 Mn |
| Dec 31, 2015 | 1.34 Mn |
| Sep 30, 2015 | 1.50 Mn |
| Jun 30, 2015 | 1.66 Mn |
| Mar 31, 2015 | 1.82 Mn |
| Dec 31, 2014 | 1.98 Mn |
| Sep 30, 2014 | 2.14 Mn |
| Jun 30, 2014 | 2.30 Mn |
| Dec 31, 2013 | 2.63 Mn |
API Access
Amphastar Pharmaceuticals Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();